Comparing IDC survival rates in cohorts sorted on the basis of NEP promoter methylation with the Cancer Browser database demonstrated that although there was no significant difference in survival across all IDC samples (Table 2), there was a significant survival difference in stage I IDC tumor samples associated with NEP methylation. Here, MME is linked to neoplasm.